with the responsibility of setting the standards for labeling prescription drugs, has recently issued a patient package insert (PPI) which accompanies each package of prescribed oral contraceptives. The purpose of the PPI is to inform the patient of potentially harmful or disturbing side effects and drug interactions so that she can report them to her physician sooner, or help to avoid them altogether. Patient package inserts are presently being prepared by the FDA for other categories of drugs in response to pressure from legislative and consumer groups who are demanding that patients have "a right to know" more about their medications.
Two questions which have recently received a great deal of attention are: "Who shall decide whether or not a patient shall receive a patient package insert?" and "Who shall distribute it to the patient?" The response of the medical profession to the PPI's has been divided. A recent editorial appearing in the Journal of the American Medical Association stated: "The final decision to give a PPI to a particular patient should be left to the physician and not legislated bureaucratically as a response to pressure groups . . . Traditionally, just what and how much to tell a patient has been a decision left to an individual physician for a unique set of circumstances with an individual patient."
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The keyword in the above statement is "traditionally." Traditionally, the physician has assumed an almost total responsibility for the care of the patient. With the knowledge explosion has come the realization that there is a need for specialization of services. Every health profession is growing in its own way to better meet the needs of the patients and, as a result, the interaction between each profession will naturally increase. Rather than feel that one profession is taking away a responsibility of another profession, we must learn to work together in solving common problems of patient management.
A few physicians are presently counseling patients very thoroughly on proper drug usage and a few are giving patients written instructions which they have personally prepared. However, the majority of physicians are ignoring this aspect of drug therapy. A similar comparison can be made with pharmacists. Only a handful of pharmacists are routinely counseling patients about the medications being dispensed. The research which has been done on patient compliance with medications has proven that noncompliance is a very serious problem which can be significantly improved through a combination of verbal and written instructions. In view of the fact that both medicine and pharmacy have been unsuccessful in solving this problem, the FDA has decided to intervene and help tackle the problem at a national level.
The patient wants the information and the FDA supports the concept of informing the patient about certain side effects and drug interactions. Pharmacists should support the FDA but should also insist that they will be responsible for distributing and verbally interpreting the PPI to the patient. Every patient should receive written instructions. If a patient is extremely anxious and the physician does not want the patient to receive a PPI, there could be a mechanism whereby the physician could telephone the pharmacist or write "Do Not Counsel" on the prescription. In this way, the medicolegal responsibility for not informing a patient would be shifted from the pharmacist to the physician. The physician should also be encouraged to instruct the patient. on Pharmacy" that took more than two years to complete, it is difficult not to be disappointed. The Commission, in the words of its chairman, "conducted its study as 'a group learning exercise' . . . hearing all testimony, debating all issues, and joining unanimously in its findings." Some eighty consultants were asked to present their views to the Commission.
There is a surprisingly bland unanimity to the Report. Were there no dissenting opinions? One is also amazed at the relative lack of documentation, and the failure to discuss in some depth the historical roots of our current problems in pharmacy. Nor is there an attempt made to evaluate previous studies such as the Elliott report (1946) (1947) (1948) (1949) and the one by D. E. Francke and his associates on hospital pharmacy (1964) . The Report could also have been improved by a comparative analysis, not necessarily lengthy, of some of the important differences and similarities between pharmacy in the United States and certain key industrialized countries. Many of the pronouncements in the Report are banal and sententious.
Early in the Report, an important question is posed: "What is pharmacy?" (Chapter 2 ) . The Commission's conclusion that pharmacy is a "health service" is hardly startling, nor would many readers be surprised to learn that pharmacy is a "knowledge system"; every learned profession can be regarded as a knowledge system. Accepting the common dictionary definition of pharmacy as "still valid," the Commission then constructs the following Procrustean model: The Commission correctly identifies significant "discontinuities" in attempting to formulate a definition of pharmacy. These occur between the prescriber and the pharmacist; between the drug manufacturer and the "dispensing pharmacist," and frequently in the process of drug usage by the patient. These "discontinuities" do not deter the Commission from gingerly advancing a definition of pharmacy that is almost a half-page long (p. 14).
Another significant question asked is: "Who are the pharmacists?" (Chapter 3). Using data compiled by Rodowskas and Dickson in 1973 on 103,340 active registered pharmacists, the Study Report classifies pharmacists by years of undergraduate education, by place of practice (community-independent and chain; hospital and nursing homes; manufacturing and distribution; government, teaching, and miscellaneous). Almost threequarters of all active registered pharmacists were in community practice, with more than fourteen percent in hospitals and nursing homes. The Study Commission admits that the Rodowskas and Dickson survey "gives some clues to the question of what pharmacists do, but it is far from definitive." The Report goes on to say that it has reviewed studies of community and hospital pharmacists and "has interviewed a large number of individuals whose testimony has given a reasonably clear picture, at least qualitatively, of the activities of pharmacists in their several work environments."
What follows is a pedestrian and superficial discussion of the activities of pharmacists that lacks rigorous quantitative data and analyses. The Study Commission states: "We cannot define a pharmacist as one who practices pharmacy. Rather, he must be defined as one who practices a part of pharmacy which is determined by the activities carried on in one of the sub-systems of the total system of pharmacy." (p. 29) This is not specialization according to the Study Commission, but something that causes the pharmacist to become "differentiated," and act as a "bivalent or polyvalent person" (p. 30). To be sure, the Commission proceeds to explain these neologisms, which seem more appropriate to science fiction than to real life, but the explanation is muddled and unconvincing. Specialization in pharmacy is a perfectly sound concept! But perhaps the main weakness of the Report is its failure to recognize that the economic structure of community pharmacy is the greatest single cause of "discontinuities" (breaks in the flow of drug information and services). In this respect the Report confirms what is generally known, that for the physician the pharmacist is the least frequently used source of information (p. 53), and pharmacists are the last to be consulted by patients for drug advice (p. 56). As for nursing homes, the Report points out that "many, if not most . . . provide inadequate pharmacy services to their patients" (p. 24). It would seem to me that the majority of these homes are circumventing the law with respect to Medicare and Medicaid patients in not obtaining the services of a qualified pharmacist. Conversely, community pharmacists are shirking their responsibilities in not making strong efforts to bring these services to nursing homes. This situation, too, can be ascribed in large measure to the economic structure of community pharmacy. If the old argument repeated in this Report is true, that the majority of nursing homes "are small and cannot afford the full-time or even the part-time services of a welltrained pharmacist" (p. 24), then I believe that these nursing homes should not be in business. I think that every nursing home should be able to afford some qualified pharmacy service. The Report, itself, seems to lend support to this view when it states that in some situations, arrangements bewteen nursing homes and community pharmacists have shown that "actual cost savings have resulted from regular monitoring of drug utilization and communication with prescribing physicians. Substantial reductions in drug use by patients have resulted and the consequent savings have more than offset the fees paid to the consulting pharmacist" (p. 24).
I firmly believe that if the dispensing function could be assigned to pharmacy technicians or technologists working under the supervision of clinical pharmacists in a health care environment, the "discontinuities" described in the Report could be bridged. The case for this view and the reforms in pharmaceutical education needed to bring this about have been most forcefully and courageously presented by Donald E. Francke on a number of occasions. (See, for example, his editorial, Prescription for Pharmacy Practice, D.I.C.P. 10:111-112 (Feb.) 1976) . If access to drug information for the pharmacist is "substantially less" than for the physician, as the Report would have us believe (p. 54), it is due rather to the apathy or ineptness of many pharmacists working in commercialized settings. "It may well take a dedicated professional to keep as up to date as he should," the Report timidly concludes (p. 55). that all pharmacists should strive to be dedicated and professional. Thus far, I have commented on only a portion of the Report, but many of the general criticisms that I stated earlier apply to the remainder of the Study Commission's findings. This does not mean that I disagree with everything in the Report. For example, I believe that the recommendation for a National Board of Pharmacy Examiners (p. 137), although not a new idea, is a sound one. Nor do I have anything but praise for the Study Commission's admonition that "The future will not permit the use of the full-trained pharmacist in procedures and tasks that do not require the level of his knowledge and skill" (p. 76). It is a pity that the Report did not explore this crucial theme in greater depth, because it has tremendous implications for the future of pharmaceutical education and professional growth.
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Toxicological Information Symposium TO THE EDITOR: The Toxicology Information Subcommittee of the Department of Health, Education, and Welfare Committee to Coordinate Toxicology and Related Programs will sponsor a "Symposium on the Handling of Toxicological Information" on Thursday and Friday, May 27-28, 1976 from 9:00 A.M. to 5:00 P.M. in the Masur Auditorium, Clinical Center, National Institutes of Health, Bethesda, Maryland. The topics to be covered during the Symposium include, toxicology and the biomedical sciences, sources of toxicological information, information activities associated with the protection of man and the environment, poison control, occupational exposures, carcinogenesis, and environmental effects, among others.
